论文部分内容阅读
Objective To compare the early stage immune reconstitution of high-and standard-risk Philadelphia chromosome-negative acute lymphoblastic leukemia(ALL)CR1 patients who had haploidentical blood and marrow stem cell transplantation(HBMT).Methods A total of49 Ph-negative ALL CR1 patients who received HBMT and had complete early stage immune reconstitution data
Objective To compare the early stage immune reconstitution of high-and standard-risk Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) CR1 patients who had haploidentical blood and marrow stem cell transplantation (HBMT). Methods A total of 49 Ph-negative ALL CR1 patients who received HBMT and had complete early stage of stage immune reconstitution data